(Q41013437)

25 September 2017

1 reference

title

Molecular staging of genitourinary malignancies (English)

1 reference

25 September 2017

Katz AE

1

1 reference

25 September 2017

De Vries GM

2

1 reference

25 September 2017

Olsson CA

3

1 reference

25 September 2017

Benson MC

4

1 reference

25 September 2017

Swanton P

5

1 reference

25 September 2017

Ikeguchi EF

6

1 reference

25 September 2017

Buttyan R

7

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

47

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

948-958

1 reference

Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Monoclonal antibodies. Their promise for tumor diagnosis, staging, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Cancer statistics, 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Invasion of the seminal vesicles by prostatic cancer: detection with transrectal sonography

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Prognostic significance of lymph nodal metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Predictive value of pathological features for progression after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Nerve-sparing radical prostatectomy: evaluation of results after 250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Structure, function, and regulation of the enzyme activity of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Prostate cancer screening: role of the digital rectal examination and prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Detection of circulating tumor cells in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Immunohistochemical localization of cathepsin B in neoplastic human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Detection of prostate-specific antigen immunoreactivity in breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Identification of bone marrow micrometastases in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription-polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Serum prostate-specific antigen and the biologic progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

The role of digital rectal examination, transrectal ultrasound, and prostate specific antigen for the detection of confined and clinically relevant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Capsular penetration in prostate cancer. Significance for natural history and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Pitfalls in preoperative staging in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

A new tumor marker for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Analysis of nm23 gene expressions in human bladder and renal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Identification of p53 gene mutations in bladder cancers and urine samples

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Molecular detection of primary bladder cancer by microsatellite analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

The polymerase chain reaction: A new tool for the detection of minimal residual disease in haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Tumor markers in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Cytogenetic and growth factor gene analysis of a renal carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900110-0

7 January 2021

10.1016/S0090-4295(96)00110-0

Identifiers

DOI

1 reference

25 September 2017

1 reference